Aurora Financial JournalBioMaxima Spółka Akcyjna (BMX.WA)
Warsaw Stock Exchange · Financial statements, TTM figures and earnings dates
In fiscal year 2023 (ended December 31, 2023), BioMaxima Spółka Akcyjna reported revenue of PLN 46.8M and net income of PLN 586.0K. Annual financial statements are available for fiscal years 2021 to 2023, taken from the company's ESEF annual reports (IFRS).
Open interactive financials →Key financials
| PLN | FY2023 2023-12-31 | FY2022 2022-12-31 | FY2021 2021-12-31 |
|---|---|---|---|
| Income statement | |||
| Revenue | PLN 46.8M | PLN 143.9M | PLN 79.1M |
| Operating income | PLN 728.0K | PLN 34.9M | PLN 13.7M |
| Net income | PLN 586.0K | PLN 28.9M | PLN 10.2M |
| Diluted EPS | PLN 0.14 | PLN 6.48 | PLN 2.29 |
| Cash flow | |||
| Operating cash flow | PLN 1.6M | PLN 37.1M | −PLN 132.0K |
| Capital expenditure | PLN 18.1M | PLN 9.9M | PLN 4.5M |
| Free cash flow | −PLN 16.5M | PLN 27.2M | −PLN 4.6M |
| Balance sheet | |||
| Cash and equivalents | PLN 1.5M | PLN 12.9M | PLN 3.0M |
| Total assets | PLN 73.8M | PLN 74.4M | PLN 61.9M |
| Total liabilities | PLN 26.8M | PLN 22.0M | PLN 32.7M |
| Shareholders' equity | PLN 47.0M | PLN 52.5M | PLN 29.2M |
TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in PLN as reported; per-share data adjusted for stock splits.
Annual reports
More on the interactive page
The full BMX.WA page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.
Open BMX.WA financials →